Related Experiment Video
Updated: Jun 23, 2026

An In vitro Model to Study Immune Responses of Human Peripheral Blood Mononuclear Cells to Human Respiratory Syncytial Virus Infection
Published on: December 11, 2013
RSV Hospitalizations in Comparison With Regional RSV Activity and Inpatient Palivizumab Administration, 2010-2013
Alexander F Glick1,2, Stephanie Kjelleren3, Annika M Hofstetter4,5,6
1New York-Presbyterian Hospital, New York, New York; alexander.glick@nyumc.org.
Insights
Pediatric respiratory syncytial virus (RSV) hospitalizations often precede regional activity. High-risk infants may need earlier RSV immunoprophylaxis due to varied hospitalization patterns.
Area of Science:
- Pediatric infectious diseases
- Epidemiology
- Public health
Background:
- Respiratory syncytial virus (RSV) is a leading cause of pediatric hospitalization.
- Understanding the timing of RSV hospitalizations relative to regional activity is crucial for resource allocation and prevention strategies.
- Palivizumab is a monoclonal antibody used for RSV immunoprophylaxis in high-risk infants.
Purpose of the Study:
- To compare the timing of pediatric respiratory syncytial virus (RSV) hospitalizations in the United States with regional RSV activity.
- To analyze the timing of inpatient palivizumab administration in relation to RSV seasons.
Main Methods:
- Characterized RSV hospitalizations from the Pediatric Health Information System (July 2010-June 2013).
- Defined RSV hospitalization and activity seasons based on surveillance data.
- Used logistic regression to identify predictors of hospitalization timing and assessed palivizumab administration timing.
Main Results:
- Mean RSV hospitalization season onset (early November) preceded regional activity season onset (early December) by 3.3 weeks.
- Nearly 10% of RSV hospitalizations occurred outside the defined regional activity season.
- Children with chronic conditions were more likely to be hospitalized after the regional activity season, while African American children were hospitalized earlier.
Conclusions:
- Significant regional variations exist in RSV hospitalization and activity patterns.
- A substantial proportion of RSV hospitalizations occur before the peak of regional RSV activity.
- Findings suggest that high-risk infants may benefit from earlier initiation of RSV immunoprophylaxis.
Objectives:
To compare pediatric respiratory syncytial virus (RSV) hospitalizations in the United States to regional RSV activity and inpatient palivizumab administration.
Methods:
We characterized inpatients, excluding newborns, with RSV from the Pediatric Health Information System (July 2010-June 2013). RSV regional activity timing was defined by the National Respiratory and Enteric Virus Surveillance System. RSV hospitalization season (defined by at least 3 SDs more than the mean regional baseline number of RSV hospitalizations for 3 consecutive weeks) was compared with RSV regional activity season (2 consecutive weeks with ≥10% RSV-positive testing). Logistic regression was used to determine predictors of hospitalization timing (ie, during or outside of regional activity season). We also assessed the timing of inpatient palivizumab administration.
Results:
There were 50 157 RSV hospitalizations. Mean RSV hospitalization season onset (early November) was 3.3 (SD 2.1) weeks before regional activity season onset (early December). Hospitalization season offset (early May) was 4.4 (SD 2.4) weeks after activity season offset (mid-April). RSV hospitalization and activity seasons lasted 18 to 32 and 13 to 23 weeks, respectively. Nearly 10% of hospitalizations occurred outside of regional activity season (regional ranges: 5.6%-22.4%). Children with chronic conditions were more likely to be hospitalized after regional activity season, whereas African American children were more likely to be hospitalized before. Inpatient palivizumab dosing was typically initiated before the start of RSV hospitalizations.
Conclusions:
There is regional variation in RSV hospitalization and activity patterns. Many RSV hospitalizations occur before regional activity season; high-risk infants may require RSV immunoprophylaxis sooner.
Related Concept Videos
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Chickenpox
Poliomyelitis
Influenza
Respiratory Syncytial Virus Disease

